4 recruiting, 2 completed, 1 terminated, 1 unknown. 4 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 4 | Recruiting 3, Terminated 1 |
| Phase 2 | 1 | Completed 1 |
Follow Ocular Myasthenia Gravis: new trials by email Literature Review of Ocular Myasthenia Gravis trials Research Report on Ocular Myasthenia Gravis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Evaluate The Long-Term Safety And Efficacy of Rozanolixizumab in Adult Participants With Ocular Myasthenia Gravis Rozanolixizumab - Ocular Myasthenia Gravis | Phase 3 | Recruiting | UCB Biopharma SRL | 100 | 2026-09-16 | 2026-10-08 |
| A Study to Evaluate the Efficacy and Safety of Rozanolixizumab in Adult Participants With Ocular Myasthenia Gravis Rozanolixizumab, Placebo - Ocular Myasthenia Gravis | Phase 3 | Recruiting | UCB Biopharma SRL | 120 | 2026-05-27 | 2026-10-09 |
| Immediate Corticosteroid Therapy and Rituximab to Prevent Generalization in Ocular Myasthenia: a PROBE Multicenter Open-label Randomized Controlled Trial. immediate treatment with corticosteroids, addition of rituximab if recurrence - Ocular Myasthenia Gravis | Phase 3 | Recruiting | Fondation Ophtalmologique Adolphe de Rothschild | 128 | 2025-04-29 | 2026-01-21 |
| Study on Correlation Between Cytomegalovirus and Ocular Myasthenia Gravis Serum acetylcholine receptor antibody, erythrocyte deposition rate, hypersensitive C protein, neostigmine test,thymus CT, low frequency repeated nerve stimulation - Ocular Myasthenia Gravis, Cytomegalovirus Infections | Unknown | XiaoYong Liu | 125 | 2021-01-01 | 2021-10-25 | |
| Efficacy of Apraclonidine Eye Drops in the Treatment of Ptosis Secondary to Myasthenia Gravis Apraclonidine Hcl 0.5% Oph Soln - Myasthenia Gravis, Ocular Myasthenia Gravis | Phase 2 | Completed | American University of Beirut Medical Center | 10 | 2020-06-01 | 2021-09-16 |
| TheRapeutic Effect of Different immunosuppressAnts on Non-Thymoma Ocular Myasthenia Gravis: a Real-world Study Symptomatic Treatment, Steroids, Immunosuppressive Agents( azathioprine, tacrolimus, Mycophenolate Mofetil) - Ocular Myasthenia Gravis | Recruiting | Tang-Du Hospital | 200 | 2019-11-04 | 2026-01-30 | |
| Ocular Mysathenia Gravis Generalization Use of nomogram for predictions of Ocular Mysathenia Gravis generalization - Ocular Myasthenia Gravis | Completed | Fondation Ophtalmologique Adolphe de Rothschild | 151 | 2017-01-01 | 2020-12-16 | |
| Efficacy of Prednisone In the Treatment of Ocular Myasthenia Prednisone, Placebo - Ocular Myasthenia Gravis | Phase 3 | Terminated | Michael Benatar | 11 | 2011-12-01 | 2017-06-02 |
Myasthenia Gravis (8) · Cytomegalovirus Infections (1)
Autoimmune Diseases (8) · Autoimmune Diseases of the Nervous System (8) · Immune System Diseases (8) · Neoplasms (8) · Neoplasms by Site (8) · Nervous System Diseases (8) · Nervous System Neoplasms (8) · Neurodegenerative Diseases (8) · Neuromuscular Diseases (8) · Neuromuscular Junction Diseases (8) · Paraneoplastic Syndromes (8) · Paraneoplastic Syndromes, Nervous System (8) · DNA Virus Infections (1) · Herpesviridae Infections (1) · Infections (1)
Prednisone (2) · Steroids (2) · rozanolixizumab (2) · Adrenal Cortex Hormones (1) · Azathioprine (1) · Mycophenolic Acid (1) · Pyridostigmine Bromide (1) · Sugars (1) · Tacrolimus (1) · apraclonidine (1)
Fondation Ophtalmologique Adolphe de Rothschild (2) · UCB Biopharma SRL (2) · American University of Beirut Medical Center (1) · Michael Benatar (1) · Tang-Du Hospital (1) · XiaoYong Liu (1)
China (4) · United States (3) · Canada (2) · France (2) · Japan (2) · Spain (2) · Lebanon (1)
Donald Sanders, MD (1) · Gil Wolfe, MD (1) · Johnny Salameh, MD (1) · Jun Guo (1) · Michael Benatar, MBChB, DPhil (1)
2025 (2)